Form 4: Bicara Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Ryan Cohlhepp, President, COO & Interim CEO and a Director of Bicara Therapeutics Inc., sold 17,500 shares of common stock on September 8, 2026.
Summary
- Option exercise/conversion: acquired 17,500 Common Stock at $3.79 ($66,322) on September 8, 2026; holds 199,141 after (Direct).
- Open-market sale: disposed of 14,058 Common Stock at $22.77 ($320,053) on September 8, 2026; holds 185,083 after (Direct).
- Open-market sale: disposed of 3,442 Common Stock at $23.43 ($80,663) on September 8, 2026; holds 181,641 after (Direct).
- Option exercise/conversion: disposed of 17,500 Stock Option (Right to Buy) on September 8, 2026; holds 34,252 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $400,716 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Ryan Cohlhepp — Director, Officer (President, COO & Interim CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Option exercise/conversion | Common Stock | 17,500 | $4 | $66.3K | 199,141 |
| 2026-09-08 | Open-market sale | Common Stock | 14,058 | $23 | $320.1K | 185,083 |
| 2026-09-08 | Open-market sale | Common Stock | 3,442 | $23 | $80.7K | 181,641 |
| 2026-09-08 | Option exercise/conversion | Stock Option (Right to Buy) | 17,500 | — | — | 34,252 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Option exercise/conversion (17,500 shares) |
| 2026-09-08 | Open-market sale (14,058 shares) |
| 2026-09-08 | Open-market sale (3,442 shares) |
| 2026-09-08 | Option exercise/conversion (17,500 shares) |
Keywords
insider transaction, Form 4, BCAX, Bicara Therapeutics Inc., bearish, Ryan Cohlhepp
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.